AKYA:NSD-Akoya Biosciences Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | NSD

Last Closing Price

USD 11.84

Change

+0.32 (+2.78)%

Market Cap

USD 0.46B

Volume

0.08M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Akoya Biosciences Inc (AKYA) Stock Analysis:
Based on the Akoya Biosciences Inc stock forecasts from 0 analysts, the average analyst target price for Akoya Biosciences Inc is not available over the next 12 months. Akoya Biosciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Akoya Biosciences Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Akoya Biosciences Inc’s stock price was USD 11.84. Akoya Biosciences Inc’s stock price has changed by -0.96% over the past week, -0.54% over the past month and +0.00% over the last year.

About

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize h ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG Intuitive Surgical Inc

-2.03 (-0.69%)

USD109.94B 66.35 56.84
HOLX Hologic Inc

+1.01 (+1.46%)

USD17.50B 9.65 7.26
MASI Masimo Corporation

-0.40 (-0.18%)

USD12.87B 57.97 49.11
XRAY DENTSPLY SIRONA Inc

-0.14 (-0.26%)

USD11.79B 28.36 14.28
RGEN Repligen Corporation

+2.97 (+1.59%)

USD10.32B 88.82 73.96
NVCR NovoCure Limited

-0.23 (-0.36%)

USD7.18B 1,480.87 4,066.85
AZTA Azenta Inc

-0.61 (-0.75%)

USD6.56B 58.97 406.97
ICUI ICU Medical Inc

-2.82 (-1.31%)

USD5.22B 43.74 18.69
STAA STAAR Surgical Company

+0.05 (+0.07%)

USD3.59B 160.83 123.68
MMSI Merit Medical Systems Inc

+0.01 (+0.02%)

USD3.26B 75.47 25.40

ETFs Containing AKYA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.66% 14% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.66% 14% F 12% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.46B 44% F 53% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 3.47 67% D+ 36% F
Price / Cash Flow Ratio -67.48 92% A- 90% A-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -63.92% 19% F 23% F
Return on Invested Capital -50.86% 22% F 16% F
Return on Assets -8.60% 31% F 30% F
Debt to Equity Ratio 180.32% 10% F 11% F
Technical Ratios  
Short Ratio 1.86 72% C- 58% F
Short Percent 3.55% 33% F 42% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector